TCL Archive Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change? January 20, 2006
TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive DCE Board Delays Decision On New Collaborative Groups In Chemoprevention November 30, 1984